Featured

2017 Self-Assessment and Exam Prep in Clinical Cardiac Electrophysiology

One hundred American Board of Internal Medicine (ABIM) style questions contributed by 38 experts in the field, provides a comprehensive review and self-assessment of knowledge in the field of Clinical Cardiac Electrophysiology.  Up to 6.75 CMEcredits/MOC points can be earned.

Access This Activity

Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study

Results were analyzed with descriptive statistics, Kaplan Meier time to event analysis, and multivariate logistic regression.Cohort and short term results are presented.

Access this activity

2017 Summits Enduring Products (with CME/MOC)

Click on the links below to learn more

Journal CME/HeartRhythm Journal: September 2017 Volume 14, Issue 9: Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead

  • Default Section Title 1
  • Default Section Title 2
  • Default Section Title 3

Permanent His-bundle pacing (HBP) has the potential to physiologically normalize wide QRS duration in patients with bundle branch block and cardiomyopathy. The purpose of this study was to assess the feasibility of incorporating a His-bundle lead for cardiac resynchronization therapy (CRT) in lieu of a coronary sinus lead.

Olujimi A. Ajijola, MD, PhD
Gaurav A. Upadhyay, MD, FHRS
Carlos Macias, MD
Kalyanam Shivkumar, MD, PhD, FHRS
Roderick Tung, MD, FHRS

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study

  • Description
  • Faculty
  • Support

The subcutaneous ICD (S-ICD) was developed to reduce short and long term complications associated with transvenous ICD leads. Early studies in the US and Europe were enriched with younger patients with less left ventricular systolic dysfunction and fewer comorbidities than transvenous ICD subjects, making comparisons between systems difficult. Following FDA approval in 2012 a prospective registry of the S-ICD was undertaken, which is the largest study of this device to date. 

Pre-implantation patients were enrolled if they met criteria for ICD, passed at least one vector in ECG screening and had a life expectancy > 1 year. Implant technique, programming and conversion testing were performed using the standard of care of investigational centers. Results were analyzed with descriptive statistics, Kaplan Meier time to event analysis, and multivariate logistic regression.

Following FDA approval of the S-ICD, a prospective study was initiated.  The cohort and short term results will be presented.

Michael R. Gold, MD, PHD, FHRS
Medical University of South Carolina
Charleston, SC

As Presented at Heart Rhythm 2017:
Late-Breaking Clinical Trials Session
C-LBCT01. Late-Breaking Clinical Trials I
Thursday, May 11, 2017

This enduring product supported in part by Boston Scientific Corporation.

2017 Self-Assessment and Exam Prep in Clinical Cardiac Electrophysiology (CCEP)

  • Description
  • CME Information
  • Learning Objectives
Members $450 Non-members $650

A total of 100 American Board of Internal Medicine (ABIM) style questions contributed by 38 experts in the field, provides a comprehensive review and self-assessment of knowledge in the field of Clinical Cardiac Electrophysiology.  Up to 6.75 CMEcredits/MOC points can be earned.

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 6.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

ABIM MAINTENANCE OF CERTIFICATION (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Upon completion of this educational activity, participants will be able to:
  1. Describe the current guidelines related to evaluation and management of patients with cardiac rhythm disturbances
  2. Describe the role of electrophysiologic testing in managing patients with bradyarrhythmias and tachyarrhythmias
  3. Identify the advantages and limitations of diagnostic electrophysiologic methods
  4. Identify the role of pharmacologic and non-pharmacologic therapies for the treatment of arrhythmias
  5. Recognize the basic electrophysiology and genetics of inherited conditions associated with cardiac arrhythmias
  6. Recognize clinical, electrocardiographic, and electrophysiologic characteristics of specific cardiac arrhythmia syndromes
  7. Interpret complex electrophysiologic and electrocardiographic tracings
  8. Interpret stored electrograms from pacemakers and ICDs

Heart Rhythm On Demand 2017

  • Description
  • Pricing
  • Heart Rhythm 2017 Program Format

Heart Rhythm On Demand 2017*
The Heart Rhythm On Demand product is comprised of the sessions and presentations from Heart Rhythm 2017. 

The focus of Heart Rhythm 2017 showcases the ideas, people, and technology that continue to propel our field forward with sessions that represented all aspects of pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, and health policy.

*Continuing Education credits are NOT available for this content

List Price = $1,295

HRS Member = $725

Non-Member = $975

HRS Member Allied/Fellows In Training = $425

*Non-Member Allied/Fellows In Training = *$525

USB Add-on  = $125

(**only available as an add-on to the purchase of online product)

 

 

 

 

 

 

 

*If you are a Non-Member Allied Professional / Fellow In Training, please Contact Usfor special pricing.

Please include your title, facility name and complete contact information.

Heart Rhythm Sessions on Demand includes hours of education broken into the following tracks:

  • Allied Professionals
  • Basic/Translational Science
  • Cardiovascular Implantable Electronic Devices and Heart Failure
  • Clinical EP and Catheter Ablation
  • Pediatric/Adult Congenital Heart Disease

NOTE - Continuing Education credits are NOT available for this content

 

Summits On Demand 2017

  • AF Summit
  • VT/VF Summit
  • Lead and Device Management Summit

AF Summit provides a comprehensive review AF ablation and evolving therapies that are changing the field. Session topics include the role of the autonomic nervous system in cause and management of AF, the ongoing challenge of longstanding persistent AF, and new technologies for AF ablation. Attendees will leave this session with advanced knowledge of this rapidly evolving field. 

 Access for Summit Attendees ONLY

VT/VF Summit provides a state-of-the-art discussion regarding all aspects of managing patients with ventricular arrhythmias.  Ablation of idiopathic VT in unusual anatomic locations, ablation of VT in structural heart disease, and an overview of the current knowledge regarding the sudden cardiac death syndrome will be discussed by experts in this field.

Access for Summit Attendees ONLY

Lead and Device Management Summit - the Lead & Device Management Summit will focus on present and future treatments of issues as well as the pros and cons of new treatment modalities.

 Access for Summit Attendees ONLY

Journal CME/HeartRhythm Journal: August 2017 Vol. 14, Issue 8: Acute efficacy, safety, and long-term clinical outcomes using the second-generation cryoballoon for pulmonary vein isolation in patients with a left common pulmonary vein: A multicenter study

  • Default Section Title 1
  • Default Section Title 2
  • Default Section Title 3

Second-generation cryoballoon (CB2)-based pulmonary vein isolation (PVI) has demonstrated encouraging clinical results in the treatment of paroxysmal (PAF) and persistent atrial fibrillation (PersAF). However, the CB2 features a maximal diameter of 28 mm, and its adaptability to anatomic variations of the pulmonary veins (PVs) might be challenging. The purpose of this study was to assess the acute efficacy, safety, and long-term clinical results of CB2-based PVI in patients with a left common pulmonary vein (LCPV).

Christian-Hendrik Heeger, MD
Verena Tscholl, MD
Erik Wissner, MD, PhD, FACC, FHRS
Thomas Fink, MD
Laura Rottner, MD
Peter Wohlmuth, PhD, MD
Barbara Bellmann, MD
Mattias Roser, MD
Shibu Mathew, MD
Christian Sohns, MD
Bruno Reißmann, MD
Christine Lemes, MD
Tilman Maurer, MD
Francesco Santoro, MD
Johannes Riedl, MD
Britta Goldmann, MD
Ulf Landmesser, MD, FESC
Feifan Ouyang, MD
Karl-Heinz Kuck, MD, FESC, FACC
Andreas Rillig, MD, FEHRA
Andreas Metzner, MD

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

Mapping and Ablation of Atrial Tachycardias and Atypical Flutters

  • Description
  • Faculty
  • CME Information

This learning pathway discusses the clinically relevant day-to-day challenges in mapping and ablation of atrial tachycardias and atypical flutters. Choose from multiple presentations that each focus on a different aspect and/or audience level of the topic via the HRS Learning Center.

Jonathan M. Kalman, MBBS, PhD, FHRS 
Royal Melbourne Hospital, Melbourne, Australia

Peter M. Kistler, MBBS, PhD
Alfred Hospital and Baker Heart and Diabetes Institute, Melbourne, Australia

Samuel J. Asirvatham, MD, FHRS
Mayo Clinic, Rochester, MN

Natasja De Groot, MD, PhD 
Erasmus Medical Center, Rotterdam, Netherlands

Edward P. Gerstenfeld, MD, FHRS
Cardiac Electrophysiology 
Univeristy of California, San Francisco

Fermin C.Garcia, MD
Hospital of the University of Pennsylvannie, Philadelphia, PA

Pierre Jais, MD 
Hôpital Haut-Lévêque, Bordeaux, France

Mark McGuire, MBBS, PhD 
Royal Prince Alfred Hospital, Sydney, Australia

CME/CE is NOT available for this activity

EP Ablation Technologies

  • Description
  • Program
  • Faculty

The activity below contains a number of presentations by world experts describing the status of different novel ablation technologies. These include a wide selection of tools ranging from the recently developed contact force sensing, and rotor mapping and ablation, to novel and futuristic ablation technologies such as extra-corporeal non-invasive ablation using Carbon ion particle therapy. The information presented provide the reader with an up-to-date summary of these technologies and a preview on how the field will look like in next 5-10 years.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Biophysics for Electrophysiologists – duration total <84 minutes
  • Contact Force Sensing During AF Ablation - Technologies, Results and Impact on Clinical Outcomes –duration < 18 minutes
  • EP on Point:  Cryoballoon vs. RF Ablation for PVI – duration <22 minutes
  • AF Ablation Tools – duration <30 minutes
  • Debate - Paroxysmal AF Ablation: Use the Force or Ice it! – duration <45 minutes
  • Debate-Cryo vs. Fry-o – duration <45 minutes
  • New Tools and Approaches for AF Management – duration <50 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

David E. Haines, MD, FHRS 
Beaumont Health
Royal Oak, MI 

Gregory F. Michaud, MD, FHRS
Brigham and Women's Hospital
Boston, MA

Andre d'Avila, MD, PhD
Hospital Cardiologico
Florianopolis, Brazil

Boaz Avitall, MD, PhD, FHRS
University of Illinois
Chicago, IL

Moussa Mansour, MD
Massachusetts General Hospital
Institute for Heart, Vascular and Stroke Care
Boston, MA

Jason Andrade BSc, FRCPC
Vancouver General Hospital and University of British Columbia
Montreal Heart Institute and Université de Montreal

Karl-Heinz Kuck, MD, FHRS
Asklepios Klinik St. Georg
Hamburg, Germany

Ellen Hoffmann, MD
Heart Center Munich-Bogenhausen
Munich, Germany

Roland R. Tilz, MD
Asklepios Klinik St. Georg 
Hamburg, Germany

Richard J. Czosek, MD, CCDS
Cincinnati Children's Hospital
Cincinnati, OH

Peter S. Fischbach, MD, MA, CCDS
Sibley Heart Center
Atlanta, GA

Petr Neuzil, MD, PhD
Na Homolce Hospital
Prague, Czech Republic

Isabel V. Deisenhofer, MD
Deutsches Herzzentrum München
Munich, Germany

Douglas Packer, MD, FHRS 
Mayo Clinic
Rochester, MN

Journal CME/HeartRhythm Journal: July 2017 Vol. 14, Issue 7: Predicting Determinants of Atrial Fibrillation or Flutter for Therapy Elucidation in Patients at Risk for Thromboembolic Events (PREDATE AF) Study

  • Default Section Title 1
  • Default Section Title 2
  • Default Section Title 3

Atrial fibrillation (AF) is the most common clinically significant cardiac rhythm disorder. There is considerable interest in screening for AF, as it is a leading cause of stroke, and oral anticoagulants (OACs) have been shown to significantly reduce the risk of stroke in patients with AF. Improved screening for AF with subsequent treatment may help improve long-term outcomes, but the optimal patient population and screening intensity are unknown. In this study, we prospectively evaluated the use of the CHA2DS2-VASc score for the prediction of new-onset AF using insertable cardiac monitors (ICMs) and examined whether this screening led to the initiation of OAC therapy.

Javed M. Nasir, MD
William Pomeroy, MD
Adam Marler, MD
Matthew Hann, MD
Tina Baykaner, MD, MPH
Ronald Jones, MD
Richard Stoll, RN
Katherine Hursey, BSN
Angela Meadows, MSN
Jennifer Walker, MSN
Steve Kindsvater, MD

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

Cryptogenic Stroke: Diagnostics and Tools to Determine Root Cause

  • Description
  • Learning Objectives
  • Faculty

Cryptogenic Stroke: Diagnostics and Tools to Determine Root Cause
Webinar Date: Oct. 26, 2016

This complimentary activity is jointly provided by the Heart Rhythm Society and National Stroke Association.

The program will educate healthcare professionals through a multi-platform case study based CME initiative, which will highlight the connection between cryptogenic stroke and atrial fibrillation, and identify cardiac monitoring as an effective tool in determining root cause.  The activity includes a 60 minute webinar and three subsequent Case Study activities designed to apply knowledge gained in viewing the enduring product.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Heart Rhythm Society designates this live activity for a maximum of 2.5 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity

Learning Objectives

Through participation in this activity, learners should be able to:

  • Explain the relationship between cryptogenic stroke and atrial fibrillation
  • Discuss different types of cardiac monitoring and define which patients might benefit
  • Identify points at which cardiac monitoring is appropriate during the course of treatment
  • Report greater confidence in recommending diagnostic tests to monitor and test for atrial fibrillation

Faculty

Gorelick picture

Philip B. Gorelick, MD, MPH, FACP
Professor, Translational Science & Molecular Medicine
Michigan State University College of Human Medicine
Medical Director, Mercy Health Hauenstein Neurosciences

Richards Picture

Mark Richards, MD, PhD, FACC, FHRS
Director, Arrhythmia Services Northwest Ohio Cardiology Consultants

The MACRA Final Rule: A 2017 Primer for Electrophysiologists

  • Description
  • Learning Objectives
  • Faculty

This forty minute complimentary on-demand webinar, presented by Michael Gold, MD, FHRS and Robert Jasak, JD, will provide an overview of the new program as it is detailed in the final rule. If you have questions while you watch the webinar, you can emailyour questions to HRS at policy@hrsonline.org.

  • Understand the MACRA framework
  • Explain the differences between the Medicare fee-for-service and MACRA payment structures
  • Discuss MACRA’s implications for heart rhythm professionals
Faculty

Michael R. Gold, MD, PhD, FHRS
President, Heart Rhythm Society

Robert Jasak, JD
Vice-President
Coverage and Payment Policy
Hart Health Strategies, Inc.

HRS Roundtable: Managing Risk of Premature and Rapid Battery Depletion

  • Description
  • Learning Objectives
  • Faculty

On October 11, 2016, the U.S. Food and Drug Administration issued a safety communication alerting health care providers and patients about premature battery depletion in a subset of St. Jude Medical ICD and CRT-D devices.

During this 70 min on-demand webinar, Dr. Gold, Dr. Van Hare, Dr. Slotwiner from the HRS, Dr. Carlson from St Jude Medical, Dr. Selzman and Ms. Paulsen from the U.S. Food and Drug Administration answer the questions submitted during a HRS-hosted Twitter Chat held on October 24, 2016. Among the questions addressed are:

  • Are issues related to lithium clusters unique to the St Jude Medical ICDs and CRT- D manufactured between January 2010 and May 2015? Are you aware of other device models or manufacturers that are affected?
  • How frequently we should interrogate the patients that have existing device?
  • Should all affected patients be on remote monitoring?
  • Were measures taken after May 2015 to mitigate the problem of premature battery depletion?

For more information about this safety alert, please visit the Society’s Safety Alert Resource Center.

  • Explain the details of the safety alert.
  • Understand the implications for patients. 
  • Discuss and answer the questions that were submitted during the twitter chat. 

Michael R. Gold, MD, PhD, FHRS
President
Heart Rhythm Society

George F. Van Hare, MD, FHRS
President-Elect
Heart Rhythm Society

David J. Slotwiner, MD, FHRS
Chair, Health Policy Committee
Heart Rhythm Society

Mark D. Carlson, MD, MA
Chief Medical Officer and Vice President Global Clinical Affairs
St Jude Medical

Jessica Paulsen
Branch Chief
Implantable Electrophysiology Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration

Kimberly Selzman, MD, FHRS
Medical officer
Implantable Electrophysiology Devices Branch
Division of Cardiovascular Devices
Office of Device Evaluation
Center for Devices and Radiological Health
U.S. Food and Drug Administration

View All Activities